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IT IS WELL KNOWN THAT THE capacity to synthesize pulmonary surfactant is enhanced by glucocorticoids (3, 16, 23, 36) . In this context glucocorticoids do not exert their effect directly on the type II pneumocytes, but rather stimulate lung fibroblasts to produce a factor, termed fibroblast-pneumocyte factor (FPF), that is capable of stimulating surfactant synthesis by alveolar type II cells in vitro (32, 33) and accelerating lung maturation in vivo (30, 31) . The chemical nature of FPF remained a mystery until Torday et al. (39) proposed that leptin has many of the characteristics of FPF. More recent research has revealed that neuregulin-1␤ (NRG1␤) also has many of these attributes and suggest that rather than being a single agent, FPF may be a complex mixture of agents capable of stimulating surfactant synthesis (10) . The secretion of surfactant phospholipids from type II cells is known to be regulated by ␤-adrenergic agonists (5, 13) that are released at the time of birth. Numerous in vitro and in vivo studies have shown that both the ␤-adrenergic receptor (␤-AR) and ␤-agonist-stimulated adenylyl cyclase activities are amplified by glucocorticoids (6, 7, 11, 17, 25, 28) . Subsequently, dexamethasone was shown to enhance transcription of the ␤-AR gene (1, 24, 26) , a consequence of it containing a glucocorticoid response element upstream of the promoter region (8) . Such heterologous stimulation of the ␤-AR activity by glucocorticoids is a physiologically important example of how other factors can influence the regulatory processes exerted by ␤-adrenergic agents (7, 18) .
In the present study it has been shown that glucocorticoids stimulate ␤-AR activity in fetal type II pneumocytes resulting in a corresponding increase in (Ϫ)-isoproterenol-induced secretion of surfactant phospholipids from those cells. The extent of this effect was examined in the presence and absence of fibroblast-conditioned media (FCM) and in cells derived from fetuses of each sex. The peptide FPF that was initially identified as a component of FCM (32, 35, 37 ) is known to mediate the stimulatory effect of glucocorticoids on surfactant phospholipid synthesis. Given that NRG1␤ is now recognized as a likely component of FPF (10) , it was examined for its ability to stimulate surfactant secretion and to mimic the effect of glucocorticoids on ␤-AR activity, ␤-AR gene expression, and (Ϫ)-isoproterenol-induced secretion of surfactant.
MATERIALS AND METHODS
Animals. Nineteen-day pregnant rats of the Wistar strain of Rattus norvegicus were used for all experiments. The full gestation period of these animals is 22 days, and fetuses were delivered ϳ3 days premature. Animals were supplied by the Animal Resource Centre (Murdoch, Australia). The mating protocol involves caging male and female rats overnight, followed by vaginal smearing the next morning. If sperm are detected, then conception is considered to have occurred. This is accurate to within 8 h of actual conception and is considered to be day 0. Sex of the fetuses was determined by differences in the external genitalia, which can be recognized as early as day 17 of gestation. The small urogenital orifice and the genital swellings are larger in males than in females. Also, the distance between the rectum and the urogenital sinus is greater in male rat fetuses (27) . All experiments complied with National Health and Medical Research Council guidelines, and were approved by the Murdoch University Animal Ethics Committee (Permit no. R2314/10).
Materials. All reagents were supplied by Sigma Aldrich (St. Louis, MO) unless otherwise stated. Eagle's minimal essential medium (MEM) and newborn bovine serum were obtained from Thermo Fisher Scientific (Waltham, MA). Radiolabeled compounds were supplied by GE Healthcare (Little Chalfont, UK). Sterilized water was obtained from a Milli-Q system (Millipore, Billerica, MA). Recombinant human NRG1␤ and recombinant rat leptin (PeproTech, Rocky Hill, NJ) were supplied as lyophilized powders and reconstituted in Milli-Q water for use. The SV total RNA isolation (catalog no. Z3100) and the OneStep RT-PCR (catalog no. 210212) kits used for RT-PCR reactions were purchased from Promega (Madison, WI) and Qiagen Sciences (Germantown, MD), respectively.
Preparation of materials for cell culture. Newborn calf serum (NBCS) was incubated with sterile, acid-washed charcoal to remove endogenous steroids as previously described (34) . Charcoal-treated serum was sterilized using a 0.22-m filter and stored at Ϫ20°C before use. Rat immunoglobulin G was either purified using the method of Hudson and Hay (19) or obtained commercially (Sigma Aldrich). Eagle's MEM was reconstituted as specified by the manufacturer and supplemented with 0.2% NaHCO 3. This mixture was then adjusted to pH 7.4 before L-glutamine, penicillin G, and streptomycin sulfate being added to final concentrations of 2.6 mM, 100 IU/ml, and 135 M, respectively. Medium was sterilized by filtration through a 0.22-m filter, and amphotericin was added to a final concentration of 3.2-3.6 g/ml. To yield complete medium, charcoaltreated NBCS was added to a final concentration of 10% serum.
Isolation of fibroblasts and type II pneumocytes. Nineteen-day pregnant rats were killed by asphyxiation with CO 2, and fetuses were delivered by caesarean section. Fetal lungs were removed, minced, and incubated with collagenase (0.05 IU/ml) for 20 min in a 37°C shaking water bath, as previously described (9, 34) . After filtration through two layers of sterile gauze, the cells were centrifuged at 20 g for 2 min, and the pellet was resuspended in serum-free medium. This suspension was plated (6 lungs/plate) on 6-cm-diameter culture plates (Corning Life Sciences, Lowell, MA). These plates were incubated for 30 min at 37°C in a humidified incubator (5% CO 2, 95% air) (Thermo Fisher Scientific) to allow adhesion of fibroblasts. Following incubation, nonadhering cells were removed by gentle swirling, and medium was replaced with serum-containing medium. The nonadhering cells were used to isolate type II pneumocytes, according to the method of Dobbs et al. (12) . Type II pneumocyte cultures were given an initial media change 24 h after plating and thereafter at 2-day intervals. After three days in culture the plates were nearly confluent and consisted of predominantly differentiated type II cells, each containing numerous lamellar bodies and being capable of both synthesis (34) and secretion (2, 9) of surfactant phosphatidylcholine.
Preparation of FCM. The medium of nearly confluent fibroblast cultures was changed to serum-free MEM with and without 100 nM dexamethasone (final concentration). After a 24-h incubation, the media were collected and stored in sterilized containers at Ϫ20°C. At the time of use, the conditioned media were thawed, heated at 60°C for 1 h [to destroy inhibitory factors known to be present in FCM (36) ], filter sterilized using a 0.22-m Millipore GS filter, and diluted 1:4 with serum-free MEM supplemented with the appropriate additive (either 100 nM dexamethasone or propylene glycol). This was applied to type II pneumocyte cultures for 24 h to test its effect on ␤-AR activity and (Ϫ)-isoproterenol-induced secretion of surfactant phospholipids.
Determination of ␤-AR activity in type II pneumocytes. Confluent type II pneumocyte cultures were incubated for a further 24 h with serum-free MEM containing 100 nM dexamethasone or the equivalent volume of propylene glycol (vehicle), with FCM (prepared as described above), or with 50 ng/ml NRG1␤. At the end of this incubation, the cells were evaluated for ␤-AR activity using a technique previously described by Lefkowitz et al. (22) . After removal of the medium the type II cells were washed with 170 mM Tris·HCl buffer, pH 7.6, containing the protease inhibitor, phenylmethylsulfonyl fluo- A: confluent cultures of rat type II pneumocytes derived from either male or female fetuses were exposed for 24 h to either serum-free minimal essential medium (MEM) or FCM with (dark gray bars, black bars) or without (white bars, light gray bars) 100 nM dexamethasone, and the ␤-AR activity was determined. B: after male-and femalederived type II cells were subjected to the same treatment regime, the level of secretion of surfactant phospholipids from the type II cells was measured during a 3-h exposure to either 1 M (Ϫ)-isoproterenol (hatched bars) or an equivalent volume of vehicle (0.01 M HCl containing ascorbate, white bars). The results represent means Ϯ SE of 3 or 4 separate experiments for ␤-AR or phospholipid secretion, respectively. Any result that is significantly different from its corresponding control is indicated with asterisks (*P Ͻ 0.05; **P Ͻ 0.01; and ***P Ͻ 0.001).
MEM
ride (10 M) and air-dried for 2 h. The cells were incubated with 5 nM of the ␤-AR radioligand [ 3 H]DHA solubilized in the same buffer. Nonspecific binding was estimated in the presence of 10 M (Ϫ)-propranolol. After 150 min incubation, the type II pneumocytes were washed three times with Tris-HCl buffer, wiped on Whatman GF/A glass-fiber filter papers, and transferred to counting vials before the determination of radioactivity. The specific receptor binding, expressed as fmol [ 3 H]DHA bound/g DNA, was determined by subtracting the amount bound in the presence of (Ϫ)-propranolol (nonspecific binding) from the amount bound in its absence (total binding).
Determination of surfactant phospholipid secretion. The medium from confluent type II cell cultures was removed and replaced with serum-free MEM containing [methyl-
3 H]choline chloride (1 Ci/ml). Following incubation for a further 24 h, the cultures were washed three times with 3 ml of balanced salts solution to remove unincorporated choline and any detached cells before adding 1.7 ml of serum-free MEM. The cells were allowed to equilibrate at 37°C in a CO 2 incubator for 1 h before removing two plates to determine the media and cellular content of radiolabeled phospholipids as previously described (4, 9) . To the remaining plates (two for each treatment) was added 17 l of MilliQ water as vehicle (control) or the indicated concentrations of NRG1␤ or leptin. The media and cellular content of radiolabeled phospholipids was again determined after 3 h incubation of the cells with the peptides. The amount of [
3 H]phospholipids secreted by cells during the 3-h incubation period was than calculated as follows:
% secretion ϭ dpm in media phospholipids ͑dpm in media phospholipids͒ ϩ (dpm in cellular phospholipids) ϫ 100 1 Confluent type II pneumocyte cultures were incubated for a further 24 h with serum-free MEM or FCM, each containing 100 nM dexamethasone or the equivalent volume of propylene glycol (vehicle), or with 50 ng/ml NRG1␤. During this time the cells were simultaneously exposed to 1 Ci/ml [methyl-
3 H]choline chloride to label surfactant phospholipids. After 24 h exposure the cells were washed three times with BSS to remove unincorporated [methyl-3 H]choline chloride, the media was replaced with 1.7 ml of serum-free MEM, and the cells were equilibrated for a further 1 h before the addition of 1 M (Ϫ)-isoproterenol or an equivalent volume of vehicle (20 g/ml of ascorbic acid in 0.01 M HCl). The amount of radiolabeled surfactant phospholipids secreted after a further 3 h was determined as described above.
RT-PCR quantification. The RT-PCR primers for GAPDH mRNA quantification were designed to include a splice junction between the forward and reverse primer thereby providing the means of distinguishing between the products of mRNA and genomic DNA based on the size of the products. Because the ␤-AR gene has no introns or splice junctions (14, 21) , it was necessary to confirm that the RNA extraction procedure, which includes the use of DNase, is sufficient to completely remove any contaminating genomic DNA. When the RNA extracts were treated with RNase before ␤-AR RT-PCR and the products subjected to agarose gel electrophoresis, the band corresponding to the ␤-AR product was completely lost indicating no genomic DNA contamination. Each of the primer sequences chosen was checked for melting temperature using Primer3 software, lack of cross reactivity with other sequences (using BLAST software), and neither primer dimer formation nor interference with reference gene primers in a multiplex reaction. The forward and reverse primer sequences chosen for GAPDH (NCBI Reference Sequence: NM_ 017008) and ␤-AR (NCBI Reference Sequence: NM_012492.2) mRNA assays as follows: GAPDH (207 bp) forward 5=-agacagccgcatcttcttgt-3= and reverse 5=-cttgccgtgggtagagtcat-3=; ␤-AR (152 bp) forward 5=-ggagacttgctgtgacttctt-3= and reverse 5=-cctcggatttgtctatcttctg-3=.
A similar rationale was used to design the TaqMan probes except that their melting temperatures were ϳ10°C higher than either of the forward and reverse primers. The probes for GAPDH and ␤-AR were designed with an Iowa Black quencher at the 3=-end and FAM (green) and HEX (yellow) covalently attached at the 5=-end, respectively, to allow the two products to be distinguished in multiplex RT-PCR reactions. The sequence of these probes is as follows: GAPDH probe, FAM dye, sequence 5=(FAM)-ccgtgtgaacggatttggccgtatc-(IABkFQ)-3=; probe ␤-AR, dye HEX, sequence 5=(HEX)-cgtatctttctacgtgcccctggt-(IABkFQ)-3=.
Total RNA from the cell pellet was extracted using the protocol for the SV Total RNA Isolation System (Promega). The RNA extracts were stored at Ϫ70°C until quantification, which involved the use of an Agilent 2100 Bioanalyzer with an Agilent RNA 6000 Pico kit (Agilent Technologies, Santa Clara, CA). The extracts were diluted such that an aliquot containing 5 ng of mRNA was added to each 25-l RT-PCR reaction. To measure relative gene expression, QIAGEN OneStep RT-PCR was undertaken using a QIAGEN Rotor-Gene Q6000 (QIAGEN, Hilden, Germany). For each RNA extract a RT-PCR reaction was set up in an ultraviolet-sterilized, RNase-free PCR tube (Corning, Tewksbury, MA) containing forward and reverse primers as well as the TaqMan probes for the reference gene (GAPDH) and the gene of interest (␤-AR). To optimize the RT-PCR conditions, a test was conducted by varying the annealing temperature between 55 and 59°C, and it was established that 57°C provided the best specificity and the highest yield of product. Thus, the reaction mixtures were incubated at 50°C for 30 min followed by denaturation at 95°C for 15 min. This was followed by 40 cycles using the following parameters; 94°C for 30 s, 57°C for 30 s, and 72°C for 60 s. The reactions were Isoproterenol-enhanced secretion (Fold increase above control) β-Adrenergic receptor (fmol/μg DNA) Fig. 2 . Correlation between ␤-AR level and (Ϫ)-isoproterenol-induced secretion of surfactant phospholipids from male-and female-derived fetal type II cells. Type II pneumocytes from male (circles) or female (squares) 19-day fetal rats were isolated, cultured, and exposed to serum-free MEM (white squares and circles), 100 nM dexamethasone (gray squares and circles), or FCM prepared in the presence of 100 nM dexamethasone (black squares and circles) as described in Fig. 1 . After 24 h incubation, the cells were washed thoroughly and either 1) the ␤-AR activity or 2) the (Ϫ)-isoproterenol-induced secretion of surfactant phospholipids was measured. The results represent means Ϯ SE of 3 or 4 separate experiments for ␤-AR or phospholipid secretion, respectively, and match the data presented in Fig. 1 .
then held at 72°C for 10 min. The RT-PCR products were then analyzed for the expression of ␤-AR (E ϭ 97%, r 2 ϭ 0.997) relative to GAPDH (E ϭ 108%, r 2 ϭ 0.999) using the method of Pfaffl (29) . Data analysis. Statistical analyses were performed using SPSS Statistics for Windows version 21.0. Either one-way or repeatedmeasures ANOVA [time course (40) ] was used to ascertain the differences between three or more experimental conditions. If significance was determined, the ANOVA was followed by Dunnett pairwise comparisons of the various groups. (Fig. 1A) . However, when the type II cells were exposed to media that had been conditioned by fibroblasts from the same gender in the presence of dexamethasone, there was an even greater increase in the ␤-AR activity to 0.30 Ϯ 0.04 (P Ͻ 0.05) and 0.41 Ϯ 0.03 (P Ͻ 0.01) fmol/g DNA in male-and female-derived cells, respectively. Thus, the greatest increase in ␤-AR activity in type II cells (1.9-fold increase) was observed when female-derived type II pneumocytes were exposed to FCM from female-derived fibroblasts. Previous observations that glucocorticoids enhance the rate of transcription of the ␤-AR gene (1, 24, 26) were shown to be consistent with the finding that the ␤-AR gene contains a glucocorticoid response element (8) .
RESULTS AND DISCUSSION

Effect of dexamethasone and FCM on ␤-AR levels and (Ϫ)-isoproterenol-induced secretion of surfactant phospholipids in fetal type II cells. ␤-AR
Given that the ␤-agonist (Ϫ)-isoproterenol is known to enhance surfactant phospholipid secretion from fetal rat type II cells through its interaction with ␤-ARs (5, 13), any change in the ␤-AR activity would be expected to also result in an elevated rate of surfactant secretion in response to (Ϫ)-isoproterenol. When type II cells derived from either male or female fetuses were incubated with dexamethasone or FCM prepared in the presence of the steroid, there was no significant change in the rate of basal surfactant phospholipid secretion (Fig. 1B) . In contrast, when type II cells from male and female fetuses were grown in the absence of dexamethasone and exposed to (Ϫ)-isoproterenol, there was a marked elevation in the rate of secretion of surfactant (1.7-and 1.9-fold, respectively; P Ͻ 0.01). This enhancement by the ␤-agonist was significantly greater if the male-and female-derived type II cells were previously exposed to dexamethasone (2.2-and 2.4-fold, respectively; P Ͻ 0.001).
When the male-and female-derived type II pneumocytes were exposed to media conditioned by fibroblasts in the presence of dexamethasone, a treatment that produced the highest level of ␤-AR activity in the type II cells, there was an even greater response to (Ϫ)-isoproterenol (3.1-and 3.8-fold, respectively; P Ͻ 0.001). Figure 2 demonstrates that there is a very strong correlation (r 2 ϭ 0.903) between the ␤-AR activity in type II cells and the extent to which (Ϫ)-isoproterenol stimulates secretion of surfactant phospholipids. Moreover, the data show that the responsiveness is greater under all conditions when the type II pneumocytes are derived from female fetuses.
Influence of NRG1␤ on surfactant phospholipid secretion. Because the (Ϫ)-isoproterenol-induced secretion of surfactant phospholipids is greatest in type II pneumocytes exposed to both dexamethasone and FCM, it suggests that a component of the conditioned media, such as FPF (35), may influence the responsiveness of these cells to the glucocorticoid. In a recent publication we proposed that one of the likely components of FPF is NRG1␤, an agent known to profoundly enhance the rate of surfactant phospholipid synthesis (10) . When directly applied to type II cells, NRG1␤ also significantly increases surfactant phospholipid secretion in a time-and concentrationdependent manner (Fig. 3, A and B) . When fetal type II pneumocytes were incubated for 3 h with NRG1␤, in the concentration range of 20 -100 ng/ml, the surfactant phospholipid secretion increased by more than twofold at each concentration. The maximal stimulation was apparent at 50 ng/ml NRG1␤ (2.4-fold; P Ͻ 0.05).
When cultured type II cells were exposed to 50 ng/ml NRG1␤ for 24 h there was also a marked increase in the activity of the ␤-AR (P Ͻ 0.05) (Fig. 4A ). This effect of the peptide was equally apparent in cells derived from either male or female fetuses. Given this stimulatory effect of NRG1␤ on ␤-AR activity, it is not surprising that, whereas (Ϫ)-isoproterenol only marginally increased the rate of secretion in control cells, it induced a 2.5-fold greater increase (P Ͻ 0.01) if the cells had been previously exposed to 50 ng/ml NRG1␤ (Fig.  4B) . It should be noted that, in those cells exposed to NRG1␤, the peptide was removed by washing the cells before the addition of the (Ϫ)-isoproterenol at the commencement of the 3-h secretory period. Thus the level of secretion in the absence The level of ␤-AR mRNA was determined using multiplex qPCR, and the data represent means Ϯ SE of the indicated no. of independent type II cells cultures in parentheses. Cultured fetal rat type II cells were exposed to serum-free minimal essential medium containing 20, 50, or 100 ng/ml of neuregulin-1␤ (NRG1␤) or an equivalent volume of water (control). After the indicated exposure time, the cells were subjected to RNA extraction, and the mRNA concentration of these extracts was quantified.
β-AR mRNA level * *** Fig. 6 . Effect of NRG1␤ on ␤-AR gene expression in type II pneumocytes. Type II cells were exposed to 20, 50, and 100 ng/ml of NRG1␤ or an equivalent volume of vehicle (control) with (black bars) or without (gray bars) 50 nM dexamethasone. After 8 h the cells were harvested, and the mRNA was extracted followed by its quantification using an Agilent 2100 Bioanalyzer. Multiplex qPCR was carried out using both GAPDH and ␤-AR primers and probes. The level of ␤-AR gene expression relative to that in control cultures was ascertained using the method of Pfaffl (29) . The results represent means Ϯ SE of 5 separate experiments, and significant differences from cells incubated with dexamethasone alone are indicated with asterisks (*P Ͻ 0.05 and ***P Ͻ 0.001).
of (Ϫ)-isoproterenol was the same in cells exposed to either NRG1␤ or vehicle (control).
As was the case with induction of ␤-AR, NRG1␤-induced elevation in the secretory response to (Ϫ)-isoproterenol was the same in type II cells derived from either male or female fetuses (Fig. 4B) . Such a finding is in contrast to that observed in cells exposed to media that had been conditioned by lung fibroblasts in the presence of dexamethasone, where the response to (Ϫ)-isoproterenol was greater when the type II cells were derived from female fetuses (Fig. 1B) . This suggests that this sex-linked difference can be attributed to the fibroblasts, which is consistent with the previously published conclusions of Torday (38) and Floros et al. (15) .
Previous studies have shown that both leptin (20, 39) and NRG1␤ (10) stimulate the rate of synthesis of surfactant components, including disaturated phosphatidylcholine, in fetal type II pneumocytes. This prompted us to investigate the effect of these two peptides on surfactant phospholipid secretion. Although leptin, at concentrations of up to 100 ng/ml, significantly elevates surfactant phospholipid synthesis (39) , it has no effect on the level of its secretion from type II cells (Fig. 5) . In contrast, NRG1␤ significantly elevated not only the synthesis (3.1-fold; P Ͻ 0.05) but also the secretion of surfactant phospholipids (Ͼ2-fold; P Ͻ 0.05, see Figs. 3B and 5) from these cells. Thus, NRG1␤ has a multifaceted effect on type II pneumocytes, which leads to a substantial increase in the production of surfactant components.
Effects of dexamethasone and NRG1␤ on ␤-AR gene expression in type II pneumocytes. Multiplex qPCR was carried out using both GAPDH and ␤-AR RT-PCR primers together with specific fluorescently tagged TaqMan probes for each of the RT-PCR products. When type II cells were exposed to 20, 50, and 100 ng/ml NRG1␤ for 2, 4, or 6 h and the relative level of ␤-AR gene expression determined, using the Pfaffl method (29) , no significant effect of NRG1␤ was observed (Table 1) . When type II cells were likewise exposed to 50 nM dexamethasone for 8 h there was a twofold increase in the level of expression of the ␤-AR gene. Moreover, although there was no significant effect of NRG1␤ alone, the ␤-AR mRNA level in cells exposed to either 50 or 100 ng/ml NRG1␤ in combination with dexamethasone was significantly greater than in cells treated with steroid alone (P Ͻ 0.05 and P Ͻ 0.001, respectively) (Fig. 6) . It is therefore apparent that NRG1␤ and dexamethasone act synergistically in their ability to enhance the level of ␤-AR mRNA within type II pneumocytes. The data also suggest that the two agents operate via different but complementary mechanisms. One possibility is that NRG1␤ may stabilize the ␤-AR mRNA, but only when expression was enhanced by exposure to glucocorticoids.
An anomalous result was the finding that exposure of type II cells to NRG1␤ for 24 h enhanced the ␤-AR activity (Fig. 4A ) despite this treatment having no significant effect on the level of ␤-AR gene expression at 2, 4, 6, or 8 h (Table 1 and Fig. 6 ). There are at least two possibilities that could account for this apparently contradictory observation. The upregulation of ␤-AR activity by NRG1␤ may be due to a transient elevation in the expression of the ␤-AR gene at some time after 8 h exposure to the peptide, leading to an enhanced activity of ␤-AR at 24 h. This suggestion is consistent with the observations that dexamethasone induces a transient elevation in the ␤-AR mRNA at 2 h but an enhanced ␤-AR activity 22 h later in adult lung tissue from both humans (24) and rats (26) . Alternatively, because the ␤-AR assay is measuring surface labeling of ␤-AR, the increase in surface ␤-AR activity upon stimulation of cells with NRG1␤ could be due to enhanced recruitment of ␤-AR receptors to the cell surface from internal vesicles. Such a mechanism would not require an increase in mRNA expression to elevate ␤-AR surface labeling.
In conclusion, it is evident from this study that the extent of glucocorticoid enhancement of ␤-AR activity and of (Ϫ)-isoproterenol-induced secretion of surfactant phospholipids in type II cells is greater in the presence of FCM. Given that FCM has been shown to contain NRG1␤, it is relevant that this peptide also stimulates both ␤-AR activity and (Ϫ)-isoproterenol-induced secretion of surfactant phospholipids. Unlike the effects generated by glucocorticoids, NRG1␤ induces virtually identical responses in type II cells derived from male or female fetuses. The observation that the response to glucocorticoids is greater in the presence of NRG1␤ is consistent with the finding that the glucocorticoid-induced stimulation of ␤-AR gene expression is also enhanced by NRG1␤. Because the effects of NRG1␤ on lung maturation are wide ranging, causing increased surfactant synthesis and secretion and stimulating the activity of ␤-AR, it is suggested that the administration of NRG1␤ might provide an improved treatment regime for neonatal respiratory distress syndrome. 
